ProKidney Gross Profit

The latest gross profit for PROK is $-2.3M as of June 2026. That compares with $530K in the prior-year period — down 527.9% year over year. That is below the sector sector average of $790M. Investors often review this figure alongside ProKidney's historical trend and sector peers before judging valuation or financial health.

Over the past year, PROK's gross profit moved from $530K to $-2.3M — a 527.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ProKidney's operating scale or balance-sheet position.

Against its sector companies, PROK currently prints $-2.3M for gross profit, while the sector average sits near $790M. That is roughly 100.3% below the sector mean. Large gaps often invite a closer look at ProKidney's growth, margins, and balance sheet.

A gross profit figure of $-2.3M for PROK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $790M. Explore the charts below for those layers of context.

After noting PROK's gross profit ($-2.3M), review year-over-year change from $530K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.